Latest Articles
- Research ArticleImmune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo–Associated Paraneoplastic Cerebellar DegenerationElise Peter, Isabelle Treilleux, Valentin Wucher, et al.July 12, 2022
- Research ArticleLong-term Effectiveness of IVIg Maintenance Therapy in 36 Patients With GAD Antibody–Positive Stiff-Person SyndromeJessica Yi, Marinos C. DalakasJuly 07, 2022
- Research ArticleParaneoplastic Cerebellar Degeneration With P/Q-VGCC vs Yo AutoantibodiesMichael Winklehner, Jan Bauer, Verena Endmayr, et al.July 07, 2022
- Clinical/Scientific NoteThe BCL2 Inhibitor Venetoclax Plus Rituximab Is Active in MYD88 Wild-Type Polyneuropathy With Anti-MAG AntibodiesChiara Briani, Andrea Visentin, Francesca Castellani, et al.July 07, 2022
- Clinical/Scientific NoteAMPA Receptor Encephalitis in a Patient With Metastatic Breast Cancer Receiving PalbociclibA Case ReportElizabeth Matthews, Barrie Schmitt, Michlene Passeri, et al.July 06, 2022
- Research ArticleYounger Age at Onset Is Associated With Worse Long-term Behavioral Outcomes in Anti-NMDA Receptor EncephalitisAnusha Yeshokumar, Eliza Gordon-Lipkin, Ana Arenivas, et al.July 06, 2022
- Research ArticleThe Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple SclerosisIngrid Anne Lie, Kristin Wesnes, Silje S. Kvistad, et al.June 23, 2022
- Research ArticleImmune Response and Safety of SARS-CoV-2 mRNA-1273 Vaccine in Patients With Myasthenia GravisDavid Reyes-Leiva, Joaquín López-Contreras, Esther Moga, et al.June 21, 2022
- CommentComment: Humoral and T-cell Immunities to SARS-CoV-2 Vaccines: Safety, Efficacy, and Challenges in Autoimmune NeurologyMarinos C. Dalakas, Josep DalmauJune 21, 2022
Pages
Advertisement
Dr. Babak Hooshmand and Dr. David Smith